Europe owes its citizens new and improved pharmaceutical legislation that puts their needs first.
The difficulties experienced by our health systems due to shortages of medicines and medical supplies did not happen only in the wake of the pandemic. Many Europeans still suffer every day.
We have repeatedly and consistently called for the creation of a European Health Union that brings true added value to EU citizens.
Europe needs new legislation that helps relocate pharmaceutical industries to Europe and incentivises breakthrough innovations on our continent.
MEPs Dolors Montserrat and Peter Liese explain more.